Name: UMIN ID:
Unique ID issued by UMIN | UMIN000036104 |
---|---|
Receipt number | R000041129 |
Scientific Title | Research on effectiveness of behavioral activation therapy for Japanese cancer patients with depression |
Date of disclosure of the study information | 2019/03/06 |
Last modified on | 2023/09/08 16:34:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/03/06 13:14:43 | ||
2 | Update | 2019/09/05 09:18:40 | Date of IRB Last follow-up date |
|
3 | Update | 2019/09/05 09:28:00 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
4 | Update | 2019/12/06 11:56:39 | Institutions |
|
5 | Update | 2019/12/17 20:37:34 | ||
6 | Update | 2019/12/17 20:40:22 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
7 | Update | 2020/08/13 18:02:35 | Homepage URL |
|
8 | Update | 2020/09/05 11:28:20 | Other related information |
|
9 | Update | 2021/03/09 15:28:02 | Other related information |
|
10 | Update | 2022/02/01 08:18:52 | Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Other related information |
|
11 | Update | 2022/03/08 09:40:03 | Recruitment status Date trial data considered complete Date analysis concluded |
|
12 | Update | 2022/03/08 09:40:40 | Number of participants that the trial has enrolled |
|
13 | Update | 2023/03/09 09:19:01 | Other related information Other related information |
|
14 | Update | 2023/09/08 16:26:22 | Recruitment status Other related information Other related information |
|
15 | Update | 2023/09/08 16:34:44 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |